These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24944605)

  • 1. A novel NF-κB inhibitor, DHMEQ, ameliorates pristane-induced lupus in mice.
    Qu H; Bian W; Xu Y
    Exp Ther Med; 2014 Jul; 8(1):100-104. PubMed ID: 24944605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
    J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
    Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
    Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
    Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
    Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic potential of dehydroxymethylepoxyquinomicin for NF-κB suppression via reactive oxygen species and unfolded protein response.
    Nakajima S; Kato H; Gu L; Takahashi S; Johno H; Umezawa K; Kitamura M
    J Immunol; 2013 Jun; 190(12):6559-69. PubMed ID: 23690471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
    Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
    Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential protective role of hepatitis B virus infection in pristane-induced lupus in mice.
    Liu X; Jiao Y; Cui B; Gao X; Xu J; Zhao Y
    Lupus; 2016 Oct; 25(11):1180-9. PubMed ID: 27125291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
    Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
    Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D; Ishikawa H; Matsumoto K; Shibata H; Motoyoshi Y; Fukuta M; Kawashimo H; Goto T; Taura N; Ichikawa T; Hamasaki K; Nakao K; Umezawa K; Eguchi K
    Int J Oncol; 2006 Sep; 29(3):713-9. PubMed ID: 16865289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protection of NF-κB inhibition on kidney injury of systemic lupus erythematosus mice may be correlated with lncRNA TUG1.
    Cao HY; Li D; Wang YP; Lu HX; Sun J; Li HB
    Kaohsiung J Med Sci; 2020 May; 36(5):354-362. PubMed ID: 31930775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
    Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O
    Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
    Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
    Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
    Suzuki E; Umezawa K
    Biomed Pharmacother; 2006 Nov; 60(9):578-86. PubMed ID: 16978829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-38, a potential therapeutic agent for lupus, inhibits lupus progression.
    Xu WD; Su LC; Fu L; Lan YY; Liu XY; Huang Q; Wu Q; Zhou J; Huang AF
    Inflamm Res; 2022 Aug; 71(7-8):963-975. PubMed ID: 35776155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts.
    Inokawa S; Watanabe T; Keino H; Sato Y; Hirakata A; Okada AA; Fukuda K; Fukushima A; Umezawa K
    Graefes Arch Clin Exp Ophthalmol; 2015 Apr; 253(4):557-63. PubMed ID: 25519802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary extra virgin olive oil attenuates kidney injury in pristane-induced SLE model via activation of HO-1/Nrf-2 antioxidant pathway and suppression of JAK/STAT, NF-κB and MAPK activation.
    Aparicio-Soto M; Sánchez-Hidalgo M; Cárdeno A; Rosillo MÁ; Sánchez-Fidalgo S; Utrilla J; Martín-Lacave I; Alarcón-de-la-Lastra C
    J Nutr Biochem; 2016 Jan; 27():278-88. PubMed ID: 26525667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
    Li D; Shi G; Wang J; Zhang D; Pan Y; Dou H; Hou Y
    Arthritis Res Ther; 2019 Apr; 21(1):105. PubMed ID: 31023362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.
    Morita S; Shinoda K; Yoshida T; Shimoda M; Kanno Y; Mizuno R; Kono H; Asanuma H; Nakagawa K; Umezawa K; Oya M
    BMC Pharmacol Toxicol; 2020 Aug; 21(1):60. PubMed ID: 32787951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.